3 completed, 1 withdrawn. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Protandim: new trials by email Literature Review of Protandim trials Research Report on Protandim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments Astaxanthin, Protandim, Melatonin - Amyotrophic Lateral Sclerosis ALS | Phase 2 | Completed | Duke University | 50 | 2024-06-12 | 2026-10-27 |
| Protandim and the Metabolic Syndrome Protandim - Metabolic Syndrome | Not applicable | Withdrawn | SomaLogic, Inc. | 2010-04-01 | 2017-10-18 | |
| Antioxidant Replacement Therapy in Patients With Alcohol Abuse Protandim - Alcohol Abuse | Phase 2 | Completed | University of Colorado, Denver | 38 | 2009-06-01 | 2013-02-07 |
| The Effect of Protandim on Non-alcoholic Steatohepatitis Protandim, Placebo - Non-Alcoholic Steatohepatitis | Not applicable | Completed | University of Colorado, Denver | 70 | 2008-07-01 | 2013-02-05 |
Alcoholism (1) · Amyotrophic Lateral Sclerosis (1) · Fatty Liver (1) · Hepatitis (1) · Metabolic Syndrome (1) · Non-alcoholic Fatty Liver Disease (1)
University of Colorado, Denver (2) · Duke University (1) · SomaLogic, Inc. (1)
United States (4)
Gregory Austin, MD, MPH (1) · Marc Moss, M.D. (1) · Robert H Eckel, MD (1)